<DOC>
	<DOCNO>NCT00196664</DOCNO>
	<brief_summary>Depression common side effect interferon treatment chronic hepatitis C. The aim study assess efficacy safety paroxetine , antidepressant agent , prevention depression induce PEG-interferon give treatment chronic hepatitis C .</brief_summary>
	<brief_title>Efficacy Paroxetine Prevention Depressive Syndrome Patients With Chronic Hepatitis C Treated PEG-Interferon Alfa Plus Ribavirin</brief_title>
	<detailed_description>The aim study assess efficacy safety paroxetine , antidepressant agent , prevention depression induce PEG-interferon give treatment chronic hepatitis C. This comparative study include two group patient randomly allocate : one paroxetine placebo . The rate depression compare 2 group</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Ribavirin</mesh_term>
	<mesh_term>Interferon-alpha</mesh_term>
	<mesh_term>Paroxetine</mesh_term>
	<criteria>Chronic hepatitis C treat PEGinterferon alfa ribavirin contraindication antiviral treatment Allergy paroxetine Current antidepressant treatment Depression diagnose MINI International Neuropsychiatric Interview ( MINI , DSM IV ) History bipolar syndrome History psychotic syndrome Treatment triptan , carbamazepine , millepertuis , methadone , oral anticoagulation Renal insufficiency HIV infection Breath feeding Contraindication PEGinterferon ribavirin</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2009</verification_date>
	<keyword>Chronic Hepatitis C</keyword>
	<keyword>Paroxetine</keyword>
	<keyword>Depression</keyword>
</DOC>